Atlas/Track record
MRTX1133: 1 trial since 2023. 1 reached Phase 1, 0 Phase 2, 0 Phase 3, 0 approved.
0 ongoing, 0 positive, 0 negative, 0 finished without posted results, 1 stopped early. Outcomes and badges come from the knowledge API as of 2026-11-02.
Where trials stop
Not in the data yet: why trials stopped. 1 of the 1 stopped trials have no classified reason yet (ClinicalTrials.gov “why stopped”, knowledge gap K1). They are counted as “reason not known yet”, never guessed.
Every trial, in order
| Start | Trial | Phase | Outcome | Status | Why stopped | |
|---|---|---|---|---|---|---|
| 2023-03 | NCT05737706↗ Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation | Phase 1 | Stopped early | Terminated | not known yet |